title: Seronegativation in early treated HIV-infected infants: frequency and potential implications on care and follow-up in a resource-limited country.
authors.forename: Anfumbom K W
authors.initials: AK
authors.lastname: Kfutwah
authors.forename: Mathurin Cyrille
authors.initials: MC
authors.lastname: Tejiokem
authors.forename: Francis N
authors.initials: FN
authors.lastname: Ateba
authors.forename: Jean Audrey
authors.initials: JA
authors.lastname: Ndongo
authors.forename: Ida Calixte
authors.initials: IC
authors.lastname: Penda
authors.forename: Paul Alain T
authors.initials: PA
authors.lastname: Ngoupo
authors.forename: Patrice
authors.initials: P
authors.lastname: Tchendjou
authors.forename: Gisele
authors.initials: G
authors.lastname: Chewa
authors.forename: Pascal
authors.initials: P
authors.lastname: Boisier
authors.forename: Christine
authors.initials: C
authors.lastname: Rouzioux
authors.forename: Josiane
authors.initials: J
authors.lastname: Warszawski
authors.forename: Albert
authors.initials: A
authors.lastname: Faye
mesh_terms: D023241:Antiretroviral Therapy, Highly Active; D002163:Cameroon; D005260:Female; D018023:HIV Seronegativity / Q000187:drug effects*; D006679:HIV Seropositivity / Q000188:drug therapy* / Q000635:transmission / Q000821:virology; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D007223:Infant; D018445:Infectious Disease Transmission, Vertical; D008297:Male; D019562:Viral Load